<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-pharmaceuticals-14-00381">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Oliveira</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Prince</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Lo</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>L.H.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>T.-C.</given-names>
   </name>
  </person-group>
  <article-title>Antiviral activity of theaflavin digallate against herpes simplex virus type 1</article-title>
  <source>Antivir. Res.</source>
  <year>2015</year>
  <volume>118</volume>
  <fpage>56</fpage>
  <lpage>67</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.03.009</pub-id>
  <pub-id pub-id-type="pmid">25818500</pub-id>
 </element-citation>
</ref>
